The outlook of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the expiry in key regions has introduced substantial risk . Investors are now grappling with the effect of lower-cost alternatives, dimini